Arformoterol Tartrate Solution
Product Images NDC 62756-277

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 62756-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-arformoterol-carton (Spl Arformoterol Carton)

Label for Arformoterol Tartrate inhalation solution, 15 mcg/2 mL, distributed by Sun Pharmaceutical Industries, Inc. The label indicates the product is for oral inhalation only and includes storage instructions to keep refrigerated or store at room temperature for up to 6 weeks. Packaging contains 30 sterile unit-dose vials, with detailed handling, storage, and usage warnings.*

FDA Label Image

Spl-arformoterol-chem-str (Spl Arformoterol Chem Stru)

Chemical structure diagram of Arformoterol Tartrate, showing the molecular components including the arformoterol molecule and tartrate moiety.*

FDA Label Image

Spl-arformoterol-figure-1 (Spl Arformoterol Figure 1)

A line graph showing the mean change in FEV1 over 12 hours postdose for Clinical Trial A at week 0 (Day 1). The x-axis represents hours postdose, and the y-axis shows mean change from baseline FEV1 in liters. Two lines compare Placebo and 15 mcg Arformoterol Tartrate Inhalation Solution BID, with Arformoterol showing a greater and sustained increase in FEV1.*

FDA Label Image

Spl-arformoterol-figure 2 (Spl Arformoterol Figure 2)

A line graph titled 'Mean Change in FEV1 Over Time for Clinical Trial A at Week 12' showing mean change from baseline FEV1 (L) on the y-axis and hours postdose on the x-axis. Two lines represent placebo and Arformoterol Tartrate 15 mcg inhalation solution BID, with the Arformoterol line showing a positive increase in FEV1 compared to placebo over a 12-hour period.*

FDA Label Image

Spl-arformoterol-ifu-fig-1 (Spl Arformoterol Ifu Fig 1)

An instructional illustration showing a hand holding a small rectangular inhaler or device, demonstrating a rotating or twisting motion as indicated by curved arrows. The image likely depicts part of the preparation or activation process for a respiratory inhalation solution.*

FDA Label Image

Spl-arformoterol-ifu-fig-2 (Spl Arformoterol Ifu Fig 2)

An instructional illustration depicting a hand holding a small bottle or vial about to dispense solution into a device labeled 'RESERVOIR'. The image shows a step in preparation or administration, related to respiratory inhalation solution usage.*

FDA Label Image

Spl-arformoterol-ifu-fig-3-4 (Spl Arformoterol Ifu Fig 3 4)

This illustration shows two labeled respiratory accessories for medication inhalation. Figure 3 depicts a mouthpiece attached to a medication nebulizer. Figure 4 depicts a face mask attached to a medication nebulizer. These are common devices used for administering inhalation therapy solutions.*

FDA Label Image

Spl-arformoterol-ifu-fig-5 (Spl Arformoterol Ifu Fig 5)

An illustration showing a compressor device labeled with the word 'COMPRESSOR' and a control knob. Connected to the compressor is a piece of tubing labeled 'TUBING.' The illustration appears to demonstrate the setup or connection of tubing to the compressor, likely related to respiratory drug administration equipment.*

FDA Label Image

Spl-arformoterol-ifu-fig-6 (Spl Arformoterol Ifu Fig 6)

Illustration showing a person using an inhalation device by placing the mouthpiece into their mouth, intended to demonstrate the proper technique for administering a respiratory inhalation solution such as Arformoterol Tartrate.*

FDA Label Image

Spl-arformoterol-label (Spl Arformoterol Label)

Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Sun Pharmaceutical Industries, Inc. It is a respiratory inhalation solution supplied as 5 sterile unit-dose vials of 2 mL each. The label includes dosage form, potency, storage instructions, and patient information URL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.